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Abstract
Background: Well-designed clinical prediction models (CPMs) often out-perform clinicians at estimating
probabilities of clinical outcomes, though their adoption by family physicians is variable. How family physicians
interact with CPMs is poorly understood, therefore a better understanding and framing within a context-sensitive
theoretical framework may improve CPM development and implementation. The aim of this study was to
investigate why family physicians do or do not use CPMs, interpreting these findings within a theoretical framework
to provide recommendations for the development and implementation of future CPMs.
Methods: Mixed methods study in North West England that comprised an online survey and focus groups.
Results: One hundred thirty eight respondents completed the survey, which found the main perceived advantages
to using CPMs were that they guided appropriate treatment (weighted rank [r] = 299; maximum r = 414
throughout), justified treatment decisions (r = 217), and incorporated a large body of evidence (r = 156). The most
commonly reported barriers to using CPMs were lack of time (r = 163), irrelevance to some patients (r = 161), and
poor integration with electronic health records (r = 147). Eighteen clinicians participated in two focus groups
(i.e. nine in each), which revealed 13 interdependent themes affecting CPM use under three overarching domains:
clinician factors, CPM factors and contextual factors. Themes were interdependent, indicating the tensions family
physicians experience in providing evidence-based care for individual patients.
Conclusions: The survey and focus groups showed that CPMs were valued when they supported clinical decision
making and were robust. Barriers to their use related to their being time-consuming, difficult to use and not always
adding value. Therefore, to be successful, CPMs should offer a relative advantage to current working, be easy to
implement, be supported by training, policy and guidelines, and fit within the organisational culture.
Keywords: Clinical prediction models, Prognostic models, Risk stratification, Diagnostic models, Clinical decision
support systems, Primary care information systems, Family physicians, Healthcare information technology adoption,
Attitude of health personnel, Practice patterns, Clinicians
Background
A clinical prediction model (CPM) calculates the prob-
ability of an outcome for a patient based on their indi-
vidual characteristics [1]. ‘Outcomes’ may refer to future
health states, such as a cardiovascular event within 10
years (e.g. QRISK [2], Framingham [3]), the presence of
current health states (e.g. deep vein thrombosis in the
Wells’ score [4]), or the severity of health states (e.g.
lower urinary tract symptom severity in the International
Prostate Symptom Score [5]). CPMs often, but not
uniformly, out-perform clinicians at predicting outcomes
[6, 7]. For example, in predicting outcomes after coron-
ary bypass surgery, clinicians significantly overestimated
the probability of operative mortality and length of stay
on intensive care compared to a CPM [8]. However,
quantitative or qualitative evaluations of the use and
impact of specific CPMs in practice are often limited or
non-existent [9].
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In the family physician context, CPMs have been in
used in some form at least since the advent of evidence
based medicine in the 1990s. Pressure on UK family
physicians to use CPMs has increased since use of
certain CPMs has been mandated in the quality and out-
comes framework [10]. CPMs are delivered in a range of
forms, from being fully integrated in the clinical infor-
mation system, to being available as a calculator on a
website (e.g. QRISK [2]), to being a simple score that the
physician calculates by hand (e.g. Wells’ score [4]).
Family Physicians deal with a wide range of problems
and are faced with an ever-growing number of relevant
guidelines to implement, many of which now recom-
mend the use of CPMs. A recent literature review found
that 58 CPMs are recommended across 243 guidelines
relevant to family physicians, covering clinical areas
including cardiovascular disease, diabetes, osteoporosis,
fractures, breast cancer, infections, and mental health
[11]. However, the adoption of CPMs by family physi-
cians is low; a recent survey of United Kingdom (UK)
family physicians found that as few as 2 % use specific
recommended CPMs [11], with similar numbers in
Germany [12]; whereas in Switzerland the number is
26 % [13], in France 32 % [14], and 35 % in Spain [15].
Some research has sought to investigate the views of
family physicians regarding CPMs, which may help
understand reasons for their low use; the majority of this
has focused on CPMs to predict cardiovascular outcomes.
Surveys of family physicians in Spain and Switzerland have
revealed doubts concerning over-simplification of risk as-
sessment, the potential for over-treatment, lack of time
and computer support [13, 15]. Interviews with UK family
physicians suggested there was considerable confusion
regarding which CPMs were the best to use (e.g. the older
versus newer CPMs), and how to use them (e.g. whether it
is legitimate to use CPM scores to demonstrate the
change in risk based on treatment) [16]. In Australia,
family physicians suggested they used CPMs when they
considered it appropriate for the patient, when they had
enough time and enough experience using CPMs [17];
whereas barriers to their use included poor software, and
the feeling that patients may misunderstand the commu-
nicated risk [18].
Relatively few studies have explored the views of family
physicians regarding CPMs unrelated to cardiovascular
disease. Two studies, in France [14] and Germany [12],
explored family physicians’ views of CPMs relating to
diabetes, osteoporosis, and depression (in addition to car-
diovascular disease). Important themes included a lack of
relevant recommendations from CPMs, a perceived lack
of accuracy, interruptions to communications with pa-
tients, and a lack of time to use them [12, 14].
Although these studies provide some insight into rea-
sons why family physicians may not use CPMs, attempts
have not yet been made to theorise family physicians’
views of CPMs. We argue that CPMs should be consid-
ered complex interventions [19, 20] because they may be
used in different ways by different physicians, such as to
guide treatment or aid communication with patients
[18]. In turn this may result in different outcomes from
their use, such as a change in treatment or modification
of clinician-patient communication [12, 14, 18]. The use
of theory is recommended in the evaluation of complex
interventions [21]. Therefore, using a theoretical frame-
work to interpret family physician’s views of CPMs
would be useful to begin to predict and generalise why
certain CPMs are not used, and provide recommenda-
tions that may improve their uptake.
The aim of this study was to investigate reasons for
use and non-use of CPMs by UK family physicians. It at-
tempts to address a gap in the literature by extending
the scope of enquiry beyond cardiovascular CPMs, and
interpreting findings within a wider theoretical frame-
work to provide recommendations for the future devel-
opment and implementation of CPMs.
Methods
Study design and setting
We conducted our study in two phases, first undertaking
a survey, then exploring the issues raised further with
respondents in focus groups. The research was set in the
North West region of England. We chose not to focus
on one type of CPM during the study in order to address
the need identified in the literature above to further in-
vestigate non-cardiovascular CPMs.
Survey study
We sent an online survey to all family physician trainers
and trainees in the NHS North Western Deanery in
February 2014 (n = 956) using SoGoSurvey [22]. Questions
addressed the advantages, barriers and enablers to using
CPMs, which could be answered using fixed responses,
ranking of (top three) preferences, and free-text (Appendix).
The survey was informed by the existing relevant CPM
literature identified above, in addition to our personal
experience in developing, implementing and using CPMs.
An initial version was piloted with six family physicians,
and refined with their feedback. To encourage partici-
pation, a tablet computer was offered in a prize-draw. A
reminder email to complete the survey was sent after 18
days, and the survey closed in March 2014. Results were
analysed using R version 3.0.2 [23]. Where participants
were asked to rank their top three preferences, each item
received a weighted rank:
r ¼ 3 x endorsed rank 1f g þ 2 x endorsed rank 2f g
þ 1 x endorsed rank 3f g:
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The maximum score for each item per participant is
therefore 3, so the overall maximum score is 3 x number
of responses.
Focus groups
Two focus groups were conducted in June 2014 by
authors BB, an academic family physician with training
and experience in qualitative methods, and MS, a statisti-
cian with experience in the development and implementa-
tion of CPMs. A total of 18 participants were included
(nine in each group) from 14 different primary care prac-
tices from across North West England (11 female; average
8 years postgraduate medical experience, ranging from 3
to y years), and each focus group lasted one hour. Parti-
cipants were recruited both from survey respondents, and
professional contacts. Prior to starting the focus groups, a
presentation and information sheet on the study aims
were given. Written consent was obtained and partici-
pants received financial reimbursement for their time.
Focus groups were semi-structured according to the fol-
lowing topics:
 What CPMs do participants use?
 How do they use them?
 What are the benefits of using CPMs?
 What are the disadvantages of using CPMs?
 What factors facilitate using CPMs?
 What factors are barriers to using CPMs?
 What do participants think of the survey results
and free-text comments?
Facilitators provided opportunities for all participants
to contribute, and discussion continued until all partici-
pants agreed there were no further issues to explore (sat-
uration was reached). Focus groups were audio-recorded
and transcribed verbatim. Thematic analysis [24] of tran-
scripts was undertaken by authors BB and SCS (SCS is
an experienced non-clinical qualitative primary care re-
searcher) using NVivo 10 Software (QSR International).
Initial inductive open coding was performed independ-
ently, and a preliminary set of themes agreed through
discussion and consensus. Transcripts were then inde-
pendently re-coded using this framework, and a final ver-
sion of themes, definitions, and illustrative quotes agreed.




The survey was completed by 138 respondents (14.4 %
response rate), 64 % of whom were within 5 years of
qualifying from medical school (Fig. 1). Most respon-
dents believed family physicians either made the right
amount of use of CPMs (77/138, 56 %) or should use
them more (56/138, 40.6 %), with 5/138 (3.6 %) not an-
swering. Participant responses when asked about ranking
the advantages, barriers and enablers to CPM use are in
Table 1. Most (125/138, 91 %) felt further training in
understanding and communicating CPM outputs would
be helpful. Two-thirds (90/138, 65 %) believed family















Fig. 1 Distribution of number of years since qualifying from medical school for survey. Participants (each bar represents a single year)
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predicting patient outcomes. Selected responses to open-
ended question are in Table 2, linked to themes that arose
from the later focus groups.
Focus groups
Following transcript analysis, 13 interdependent themes
emerged as influential in determining family physicians’
use of CPMs. These were grouped into three domains
(Fig. 2): clinician factors (themes: clinical confidence and
experience; knowledge of CPMs; perceived effects on
personalised care; perceived threat to professionalism;
perceived effects on communication), CPM factors (themes:
actionability; ease of use; use of patient-reported measures;
rapid evolution) and contextual factors (themes: mandated;
time pressure; fear of litigation; environment and culture).
These are explained in more detail below.
Clinician factors
If a participant felt confident in their clinical skills, they
reported using CPMs less in that clinical area. Con-
versely, if participants felt less confident, they often used
CPMs to compensate for a perceived lack of knowledge.
Other participants used CPMs to guide clinical assess-
ments and treatment decisions, in an effort to improve
and standardise care.
Many participants felt that more experienced doctors
were less likely to use CPMs, in part due to their greater
clinical confidence, and the culture in which they trained
where CPMs were not as widely available.
Most participants were unaware of the evidence be-
hind CPMs and felt that addressing this would promote
their use. However, those that were aware of the evi-
dence were cognizant of CPM limitations, which they
used to inform discussions with their patients to provide
personalised care.
All participants believed CPMs could both facilitate
and impede communication during clinical encounters.
Table 1 Advantages, barriers and potential enablers of CPMs as
endorsed by survey respondents; in weighted rank (r) order.
Additionally, ‘% 1’ denotes the percentage of time an element
was endorsed as the top-ranking
Advantages r % 1
Guides appropriate treatment 299 53
Justifies treatment decisions made 217 20
Incorporates large body of evidence 156 19
Motivates patient to make lifestyle changes 70 4
Promotes equity of treatment 62 4
Scores QOF points 21 1
Other 4 1
Barriers
Do not have time to use during a consultation 163 24
Not relevant for use in all patients 161 19
Not integrated with electronic patient records 147 21
Do not know which risk score to use 103 12
Do not include all risk factors 92 9
Lack of link to clinical actions 63 6
Do not add to my clinical judgement 42 3
Encourage over-treatment 34 4
Encourage under-treatment 11 1
Other 8 1
Undermine my professionalism 4 1
Enablers
Ensure good treatment decisions 133 16
Integration with electronic patient records 131 22
Quick to use 126 17
Strong link to clinical action 109 12
Add value to clinical judgement 93 12
Provides justification for clinical decisions 82 9
Easy to use 80 9
Transparency of the methods behind the risk score 32 2
Motivate patient to make lifestyle changes 27 1
Well incentivised 9 1
Other 0 0
Key – QOF Quality and Outcomes Framework
It depends how confident you are, in your decision making… like the
PHQ-9 I am confident enough taking a mental health history and a
depression history… I don’t feel that that score replaces my own
clinical judgement but there would be some scores where you know
I would feel that if the score told me something that I wasn’t sure of
I would rely on the score more than my own because I don’t feel my
own clinical acumen is good enough in that area to replace the score.
FG2R9 (family physician, medically qualified 10 years)
What the problem is, what has happened is, we learnt it by I don’t
know 100 h a week and a few people, you know disasters happening.
Now there is much more, there is much more medical senior
supervision at a junior level, so there is probably less likely that the
disasters will happen nowadays and you are relying on the scores…
FG2R2 (family physician, medically qualified 25 years)
If there is somebody who is a lot older and you know the evidence for
statins stops there is a cut off isn’t there and beyond that age, is it
about 80, 85 you know sure it is probably going to have benefit but
how much benefit is it going to have overall, what am I doing to this
patient and the side effects… so it is about that conversation and
saying what do you think?… and there is a difference between that
person and the 40 year old as you said who overall their cumulative risk
is much, much higher to them it is probably much more important.
FG2R8 (family physician trainee, medically qualified 5 years)
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Some reported using CPMs as a segue into questions
about potentially sensitive subjects like alcohol intake in
the CAGE questionnaire [25] or suicidal ideation in the
Patient Health Questionnaire (PHQ-9) [26]. They felt if
they asked these questions in natural discourse it may
adversely affect rapport, so used the CPM as an ‘excuse’ to
broach these topics. Some reported avoiding difficult
questions altogether by requiring patients to fill out a form
comprising CPM questions. CPMs were also reported as
helpful in communicating risk to patients, to inform dis-
cussion regarding their management and support shared
decision-making. In this context, CPMs were found useful
in both introducing statistical risk as a concept and also as
a visual aid where one was provided, such as the QRISK
website [27]. Conversely, some participants found CPMs
could inhibit communication with patients. This was
highlighted as problematic in sensitive or emotionally
charged encounters where using a CPM could either
interfere with the questions the doctor wanted to ask,
or interrupt the consultation as the doctor’s attention
was diverted to calculating or recording the CPM
results.
Table 2 Selected responses to open-ended survey question and links to related themes from focus groups
Response to open-ended survey question Related themes from focus groups
Risk scores can be very useful in their place to guide treatment or investigation. The overall
clinical picture can only be gained from a clinician, so they cannot replace all thought.
Perceived threat to professionalism
Perceived effects on personalised care
Population risk doesn’t equal individual patient risk; these scoring systems should be used to
aid discussion and communication, not as an end or decision-maker. Other scoring tools
(e.g. Oxford ortho scores, IPSS, GAD-6 etc) don’t necessarily reflect ‘risk’ but are similar in
their use in communication & negotiation with patients. Linking scoring tools to read codes
can be useful (in the same way entering a Read code will bring up web mentor topics on
EMIS for example) in assisting the clinician to utilise these tools - otherwise it’s a case of
remembering the right tool and searching for it on the web.
Perceived effects on personalised care
Perceived effects on communication
Ease of use
Risk scores are often suggested from small pieces of research. They don’t always help
guide decisions, and there is a struggle between usability and being comprehensive that
many scores don’t achieve. I hate stretched acronyms (like CHADS2-VASC) where you




Ultimately it is a computer generated score. It can’t replace clinical judgement however
once you use it and document it, from a medico legal aspect, you have to be very
confident and brave to ignore it and often this is the barrier to using it as opposed to
clinical judgement in the first place. I probably use it more to add weight to my decisions.
Fear of litigation
Have seen both sides - man with a healthy lifestyle in 70s score 50 % on QRISK making him
feel there was little point to his lifestyle improvements and a very unhealthy man
(obese, drinker) etc who scored lowly so then thought he had justification to continue
with his unhealthy lifestyle - risk scores useful when used with clinical judgement
Perceived effects on personalised care
Only useful if the basic statistical and trial data is understood by the doctor doesnt always
apply to the patient/ population in front of you
Perceived effects on personalised care
Risk scores are very important, especially in general practice, but clinical judgement always
reigns supreme. I like showing patients their QRISK2 score and what would happen to their
risk were they to stop smoking for example. But barely-existent integration of such scores
undermines their use in day-to-day consultations. Most family physician clinical systems
are very poorly designed, and this is something I am planning to take up as a challenge
once I complete my training and get settled.
Perceived effects on communication
Ease of use
I think younger Family physicians / trainees are more aware of risk scores eg CURBS,
Wells (how to use Well’s properly which is drilled into us as foundation years but
Family physicians often may not know how to use properly)
Knowledge of CPMs
Clinical confidence and experience
The alcohol one I found useful, purely because it feels less like
nagging, so you can actually ask questions you can sort of, it’s like
sexual health questions if you have a pro-forma you can… we ask
these questions to everyone, and you can ask things that you
wouldn’t be comfortable going through normally and you can get a
lot more information out… I think the problem is and I sort of
watched it on videos as well, is that they are very vulnerable and
for them to start opening up and I have seen it on video and then
you start tap, tap, tapping at a screen, it is partly it is that thing of
all the stuff I am telling you is going onto that screen, there is that
element of it, and it breaks the consultation. I have watched it and
you can see patients just start to shrink back again because it’s I
am just trying to tell you something really difficult, for me to talk
and you are tapping away on your bloody computer it just, I hate,
that is why I hate using them.
FG2R5 (family physician, medically qualified 18 years)
But it might introduce the idea in the first instance, which if you
had continued intervention might sustain so like I know that in one
of the family physician surgeries I worked at, you could make the
QRisk into like a grid of 100 like sad faces, for like a bad outcome
or a happy face to a good outcome, and I think that does help the
patient because you could change like if you changed the smoking
and you could suddenly have like a million more happy faces, like it
seems really basic but it gives them like a pictorial representative
which I think can help with the initial stages but it won’t like you
said it is not going to be a sustained thing if you just expect that
to carry on.
FG1R7 (family physician trainee, medically qualified 3 years)
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Most participants reported using CPMs when commu-
nicating the clinical status of patients to secondary care
when arranging a referral. Where the CPM output
agreed with their clinical opinion that referral was indi-
cated, the information was usually communicated and
the CPM viewed positively. However, if the CPM’s out-
put conflicted with their opinion, this information was
often not shared voluntarily unless the discrepancy could
be explained. If the receiving clinician subsequently re-
quested the CPM’s output, participants viewed the CPM
as a hindrance as it could be used to block the referral.
Some participants voiced concern about the risk of
uncritically using or over-relying on CPMs. They felt
that using CPMs was a threat to their professionalism as
it over-simplified their complex clinical skills, and could
be viewed as a shortcut. Furthermore, they felt that be-
cause CPMs are derived from population averages, their
outputs might not be relevant to individual patients.
This reduced their ability to provide personalised care,
which could lead to problems such as over-medicalisation.
However, through discussion, some participants managed
these CPM limitations with patients as highlighted above.
Consequently, CPMs were often used judiciously, which
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Fig. 2 Themes and their interactions arising from focus groups
I think because it just gives you a standard doesn’t it, that you are sort
of both [referring and receiving clinician] singing from that same hymn
sheet so everyone knows what they are looking at whereas before it
was very descriptive for DVT [deep vein thrombosis]… and it’s, now it is
well if they hit this rating then they almost have to accept them so it
just makes it easier to and things like the sort of TIA [transient ischaemic
attack ABCD2 score]… all those things, it just means that you, you are
speaking the same language with someone on the phone who hasn’t
actually got the patient in front of you.
FG2R5 (family physician, medically qualified 18 years)
I would say probably more [the] case in secondary care, partly because
the pressure for the juniors there is not to admit people, and so people
tend, and unfortunately be very defensive and so they will use tools
that are meant to be there as tools, they will use them as tools to reject
admissions.
FG2R8 (family physician trainee, medically qualified 5 years)
I think the problem is you see, because you are dealing with an
individual, when you are using the score you are using it on an
individual basis, but you are right it’s been based on a population
aggregate, so therefore, you can’t just rely on the score you have to
have clinical acumen as well.
FG2R2 (family physician, medically qualified 25 years)
Yes probably, we get it all the time with like Wells’ score for DVT, and
people with chronic immune insufficiency so, little old ladies with huge
legs, really common thing you see in family physician, and they are
always immobile, erm… you know they have always got a couple of
other things that would give them every day of their life they have got
a Wells’ score of 3, but every time you go and see them you don’t write
the Wells’ score down because you don’t, they have not got a DVT and
both legs are the same but you see just, you just deliberately think well,
I am not going to write that down I am just going to focus on what the
clinical problem is. Because you almost, yes you don’t want to go there
so you just don’t use the score.
FG1R8 (family physician trainee, medically qualified 3 years)
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CPM factors
Regular updates to CPMs means that participants were
unlikely to have a comprehensive knowledge of all
current models relevant to their practice. Almost all par-
ticipants were more likely to use a CPM if its outputs
were actionable – i.e. associated with a specific clinical
action, such as statin prescription with QRISK [2], or re-
ferral urgency for a transient ischaemic attack with the
ABCD2 score [28]. Accordingly, they were less likely to
use a CPM if was perceived as less actionable e.g. those
used to estimate symptom severity such as the PHQ-9
for depression [26]. As a workaround, some participants
reported such CPMs to monitor change in a patient’s
condition, which they could then use to guide clinical
action or facilitate communication with patients or
colleagues.
There was scepticism of CPMs that relied solely on
patient-reported symptoms rather than physiological
variables such as blood pressure. Most participants
felt that patient-reported symptoms were less object-
ive and therefore less accurate, with the potential for
patients to exaggerate. This seemed to contradict how
CPMs were used in situations to facilitate commu-
nication with patients and monitor their symptom
severity.
Almost all participants reported they were more likely
to use CPMs that were easy and quick to use, for
example those where the electronic health record (EHR)
automatically performed the calculation. This was
enhanced if the EHR reminded them to complete the
CPM during the clinical encounter.
Contextual factors
One of the strongest factors nearly all participants
reported determining their CPM use was whether or not
they were mandatory. This could be through national
clinical guidelines, local policies or the Quality and
Outcomes Framework (QOF; the national pay-for-
performance scheme in UK primary care) [29]. The issue
of mandate was augmented by professional norms, spe-
cifically whether there was a culture of using CPMs by
colleagues. A contrast between primary and secondary
care was noted, where participants felt CPMs were used
more frequently in the latter. This was felt by partici-
pants to partly explain why less experienced family
physicians reported using CPMs more readily (as de-
scribed under ‘clinician factors’) given they had more
recently worked in secondary care compared with
their more senior colleagues.
Fear of litigation determined whether some partici-
pants used CPMs. When the CPM outputs indicated low
risk for a potentially important outcome (e.g. pulmonary
embolism) this was sometimes documented in patient’s
medical records to demonstrate that a relevant clinical
option had been considered and validly excluded.
Conversely, if a CPM output was anticipated to indicate
high risk and hence further action, the CPM was not
used if this anticipated output was discordant with the
…with more something like PHQ-9 or something, you cannot see
objectively if there is much response to treatment so if they come in
and they are originally 26 out of 27 and then a year later they only
report themselves as a 13 you know objectively there has been
progress in kind of the outcome.
FG2R7 (family physician trainee, medically qualified 3 years)
Well it’s the ones that you, its subjective you can’t measure them
so you haven’t got a, you know a number to support, to support
it as such so when you ask the patient and there is a range of
responses, the Epworth [Sleepiness Scale] is a good example, you
know recall is not always 100 % accurate, so they may well doze off
in certain scenarios, and people may have a different interpretation
what they class as low, high or moderate chance of dozing off and
that would skew the score. Some people come with a score of 24
and are slim and they clearly haven’t got sleep apnoea whereas
some people might have an 8 or a 9…. It is a bit of crystal ball
gazing isn’t it, because the ones where you have basically got
numbers like systolic blood pressure, LDL cholesterol whatever the
ones where you have got actual numbers, that, that it trumps your
acumen frankly because you know you can’t, that is done on an
epidemiological average study of how likely this chap is to have a
vascular event in the next 10 years or whatever, you can’t crystal
ball gaze the ones where it is about the, the here and now and
there is lots of subjectivity within the score
FG2R6 (family physician, medically qualified 10 years)
I think it is a major point that if something does flash up on [an EHR]
and you have to fill it in, then you will as opposed to if you have to
search through something and it says click on this link and it takes you
to like four webpages then it won’t get filled in. I think in just the reality
of the situation.
FG1R2 (family physician trainee, medically qualified 5 years)
I think I mean I use them but probably I only use them because we are
told to use them in guidance, CHADS2 VASC you are told to use it in
AF [atrial fibrillation] guidance you know… QRISK we have to use it,
to justify decision making and statins and things like that, Epworth
[Sleepiness Scale] I was told we have to use Epworth if we are referring
to the sleep clinic.
FG2R9 (family physician, medically qualified 10 years)
I think that is definitely truer at the more junior level, in these more
process driven environments like A&E because I am [a trainee family
physician] and I remember in A&E there are sort of proformas almost
based on risk scores for assessing certain conditions and that does help
you almost learn the questions that you should be asking to assess
someone and if it does change as you get more senior and move into
general practice it is a lot less process driven and it is a lot more
practitioner driven, then it very much will depend on what your own
personal awareness is of the scores, whether you actually choose to use
one rather than kind of being forced to use one, because that is like the
rules of the department that you might be working in
FG1R2 (family physician trainee, medically qualified 5 years)
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participant’s clinical judgment. This was similar to par-
ticipants not using CPMs when they reduced their per-
ceived ability to provide personalised patient care. Fear
of litigation was more pronounced in more junior partic-
ipants perhaps due to lower confidence, and influenced
by the culture of the participants’ working environment.
Most participants reported lack of time as a key reason
for not using CPMs. This was mitigated if the CPM was
quicker and easier to use, if the CPM’s output was action-
able or could facilitate communication with the patient or
a colleague, or if use of the CPM was mandatory. Primary
care was felt to have more time pressure than secondary
care.
Discussion
Summary and interpretation of findings
This mixed methods study explored factors influencing
CPM use as reported by UK family physicians. Our
survey identified the main advantages to using CPMs
were: to guide appropriate treatment, to justify treat-
ment decisions, and to incorporate a large evidence base.
The most endorsed barriers were: lack of time, irrele-
vance to some patients, and poor integration with EHRs.
Focus groups found 13 themes to explain CPM use cov-
ering three domains: clinician factors, CPM factors and
contextual factors. Many of these themes were inter-
dependent (Fig. 2), highlighting the tensions that clini-
cians face, such as providing evidence based care that is
also personalised and informed by clinical judgement, or
to balance the use of CPMs between facilitating and
inhibiting communication with patients.
Diffusion of Innovations theory in health service orga-
nisations states that whether innovations are adopted is
determined by features of the innovation, the adopters,
and wider context [30]. These categories are analogous
to the broad thematic domains of CPM, clinician, and
contextual factors derived from our focus groups, hence
we used Diffusions of Innovations theory to frame our
results.
Many of the reasons for use and non-use of CPMs we
found can be explained by the concept of ‘relative ad-
vantage’ [30]. Diffusion of Innovations theory posits that
innovations must have a clear unambiguous advantage
over usual ways of working to be readily adopted. This
was demonstrated in the survey, where the most endorsed
advantages of CPMs were to guide and justify appropriate
treatment. This was also seen in focus groups where par-
ticipants reported using CPMs in situations where their
clinical knowledge was weak, and where CPMs were felt
to enhance communication with colleagues and patients.
However, our results also demonstrated that use of CPMs
may be more complex than this. The potential advantage
may be more ambiguous, such as where they served a role
in medico-legal protection for the physician. A perceived
lack of relative advantage was demonstrated in the survey
with the finding that most (90/138, 65 %) respondents be-
lieved that family physicians could regularly out-perform
CPMs in predicting patient outcomes. On the other hand,
a lack of link to a clinical action, and irrelevance to a pa-
tient were some of the highest ranked barriers to using
CPMs. Similarly, in the focus groups, participants reported
using CPMs less, or not at all, when it was felt that CPMs
did not provide an advantage, or imposed a relative disad-
vantage, such as interfering with doctor-patient communi-
cation, or the provision of personalised care.
Further explanations of our results by Diffusion of In-
novations theory relate to the constructs of ‘complexity’,
‘compatibility’, ‘dedicated time and resources’, ‘political di-
rectives’ and ‘participants’ concerns’ [30]. With respect
to complexity, innovations that are perceived by clini-
cians as simple to use are more readily adopted. This
was particularly true if they were automated, and physi-
cians were reminded to use them within the EHR; this
feature was also highly endorsed by survey respondents.
Innovations that are compatible with the intended
adopters’ values, norms, and perceived needs are more
readily adopted. This is congruous with our finding of
the importance of culture of use of CPMs within a fam-
ily physician practice in determining whether or not they
are used.
A lack of time is recognised as an important determin-
ant of a whether an innovation is adopted (‘dedicated
time and resources’). This was the highest ranked barrier
to using CPMs in the survey, which was further empha-
sised within the focus groups with regards to the lack of
time for using CPMs within a clinical consultation.
Political directives are acknowledged in Diffusion of
Innovations theory as effective drivers for organisations
to adopt innovations. This is consistent with our find-
ings that clinical guidelines and local policies mandating
the use of CPMs are effective at increasing their uptake.
In some ways if you think they don’t really have clot or a DVT you are
kind of using it really for medico-legal point of view because you don’t
actually believe this patient does but just in case you know they do ever
turn out to have a clot or PE then hopefully this will now show that I
kind of considered all the other factors.
FG2R3 (family physician trainee, medically qualified 5 years)
I mean it’s ultimately what you are going to get out of it, in a 10 min
consultation so if you are going to use it for those things… because
you have to do it for QOF because you have to do it to augment a
referral or get the referral in, if you have to do it for persuasion… you
know you will use that in a 10 min consultation but if it doesn’t confer
you any benefit to do that… with time constraints you are going to go
to your, if you like less measured, softer clinical skills in how you find
the patient.
FG2R6 (family physician, medically qualified 10 years)
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The Concerns Based Adoption model in Diffusion of
Innovations theory suggests that in the pre-adoption
phase, intended users must be aware of the innovation
and have sufficient information about what it does and
how to use it [30]. This explains why nearly all (125/138,
91 %) of survey respondents felt they needed further
training in the use of CPMs. It also explains why focus
groups revealed that regular updates to CPMs are a
barrier to their use, because it reduces family physicians’
familiarity with their correct application.
Comparison with existing literature
Other literature supports the consideration of CPMs as
innovations, which should be viewed in a wider theoret-
ical framework [19]. The notion of disruptive innovation,
creating a new ‘market’ in clinical decision making may
also apply [31]. The ‘disruption’ emphasises the activa-
tion energy required to change practitioners from a
largely CPM-absent to a CPM-supported decision making
norm [32].
Using this theoretical lens, our findings can also be
compared with the existing literature into family physi-
cian’s use of CPMs. Barriers to using CPMs found in
studies regarding concerns of over-simplification of risk
assessment and a perceived lack of accuracy [12–15] re-
late to the notion of relative advantage, which suggests
that if CPMs are not perceived as more effective than
the current way of working they will not be adopted.
The feeling that CPMs may lead to over-treatment of
patients [13, 15] can be viewed as a manifestation of
‘compatibility’ in that family physicians strive to provide
personalised care. If CPMs are perceived to interfere
with this, they will not be used. Finally, findings that
family physicians expressed confusion regarding which
CPMs to use and how to use them [16], relate to the
Concerns Based Adoption model and the prerequisite
that intended adopters should have sufficient informa-
tion about what an innovation does and how they should
use it for effective uptake.
Some of our findings are supported by other studies of
family physician views of CPMs. For example, our finding
that a lack of time to use CPMs and software support are
important barriers to their use have been demon-
strated in Spain, Switzerland, France, Germany, and
Australia [12–15, 17]. Our notion of actionability as a
facilitator to CPM use is supported by observations in
Germany, where a lack of relevant lifestyle-related
recommendations for healthy patients prevented fam-
ily physicians from using CPMs [12]. Our finding that
using CPMs may impede (as well as improve) communi-
cation with patients and colleagues is mirrored by a study
in France where family physicians stated they did not use
CPMs if they interrupted the flow of the clinical con-
sultation, though did use them to convey information in
specialist referrals [14]. An interesting insight into action-
ability is offered by a recent study of a specific CPM in the
UK [33], which highlighted another way in which a CPM
may not be actionable – where a recommended service is
not available.
Our study also makes new contributions to the litera-
ture. We found that UK primary care clinicians use
CPMs for purposes not previously reported, such as
communicating with other clinicians, for medico-legal
purposes, and to legitimise asking patients difficult ques-
tions. We also identified new CPM features that may in-
fluence their use, such as the potential barrier of using
patient-reported data to generate CPM outputs, and the
potential enabler of linking CPM results to a defined
clinical action (actionability). Our findings also suggest a
complexity and tension between different factors that
influence CPM use that has not previously been reported
(Fig. 2). This arguably contradicts the overly simplistic
application of terms such as ‘barriers’ and ‘enablers’ to the
use of CPMs, as has been previously observed in
other studies of evidence based medicine in UK primary
care [34].
Strengths and limitations
Using focus groups in addition to a survey allowed dee-
per exploration of issues identified within the survey,
and revealed complexities in family physician’s views of
CPMs. We did not focus on participant views of CPMs
in a particular clinical area, such as cardiovascular dis-
ease, to enable a wider range of views and characteristics
of CPMs to be explored. However, our general focus
may have prevented a more in-depth analysis of issues
with specific types of CPM. Although useful for under-
standing participant views, both surveys and interviews
are susceptible to recall bias. For example, there may be
additional reasons that physicians use (or do not use)
CPMs that are only apparent following observation by
someone else.
Our survey response rate was low (14.4 %), though in
similar studies the response rate could not be calculated
[11], and where it has been reported is comparable to
our own [35]. Nevertheless, a low response rate may
have biased our survey towards participants that are in-
terested in CPMs and were therefore more motivated to
complete the survey. This may have resulted in more ex-
treme views than the wider family physician population.
Moreover, the survey was sent to a list of trainers and
trainees, hence clinicians who were neither of these were
not reached, and there was also a bias towards newly
qualified clinicians. As we used the survey to also recruit
participants for focus groups this may also have influ-
enced their findings, though in contrast to surveys, hav-
ing respondents with an interest in the topic matter can
be advantageous in capturing diversity of opinions [36].
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Finally, we limited our study to one region of England,
so the views reported here may not be representative of
the wider family physician population.
Implications for practice and research
Our findings, and their interpretation within a wider
theoretical framework, provide new insights into how
primary care clinicians use CPMs, which are relevant for
the future development and implementation of CPMs.
Table 3 summarises best practices for development and
implementation of CPMs in primary care. Primarily, and
as also argued by others [19], we suggest that CPMs
should be considered as innovations, driven by ongoing
science and technology, which are applied in complex
clinical environments. To ensure CPMs are successfully
adopted, attention should be paid to the factors relating
to the CPM itself, the clinicians intended to use it, and
the context. Any new CPM that is intended for imple-
mentation should thus be thoroughly evaluated using
both quantitative and qualitative methods to ensure that
their inherent complexity is captured. Such evaluations
are, at present, usually inadequate [9].
CPM factors
Particular consideration should be given to the ‘relative
advantage’ of the CPM, as it is more likely to be used if it
seemed to be a more effective way of working than the sta-
tus quo. Examples of how this could be achieved as dem-
onstrated by our results are to focus CPM development in
clinical areas where there is a perceived lack of clinical
knowledge, or to ensure that their outputs are linked to
clinical actions, as has also been highlighted in other
studies [12]. CPMs should be as simple and easy to use as
possible. Our results suggest this may be achieved by inte-
grating them with clinical information systems, including
automatic extraction of relevant input data and recording
of (actioned) model estimates. This automation could
negate problems when CPMs are revised. Particular care
would be needed to handle a situation where the revision
means a patient’s risk crosses a clinically significant
boundary – including alerting the clinician to this fact
and justifying why the revised evidence now supports
a new proposed action.
Clinician factors
As demonstrated in our findings, and in those of related
studies [16], clinicians must be made aware of new
CPMs, and if existing ones are updated. They should
also be provided with enough information regarding
what it does and how to use it [30]. This could be
achieved through targeted training, which could also ad-
dress the misconception highlighted in our results that
most family physicians (90/138, 65 %) believe they can
out-perform a CPM in predicting patient outcomes [6, 7].
Guidance on how CPMs could, should (and should not)
be used, along with their potential benefits, in ways con-
sistent with the provision of personalised care should be
available. This should include acknowledging their limits
in specific patient groups, or highlighting the risks of
over-treatment if used uncritically. Such guidance could
recommend using model outputs as a basis for communi-
cating risk and exploring treatment options with patients
(both medication and lifestyle-related), as some of our
participants demonstrated. This would go some way to
address the concerns demonstrated by our participants
regarding tensions between the use of CPMs and the
provision of personalised care, in addition to those
highlighted in other studies about over-simplification of
risk and over-treatment [12–15]. Providing this informa-
tion would also address the issue of perceived ‘relative
advantage’.
Contextual factors
CPMs are unlikely to be used in organisations where
they are incompatible with the pervading culture, such
as attitude towards evidence-based medicine, or there is
a disinterest in the clinical condition the CPM addresses.
This may be counteracted by relevant education or
training. ‘Political directives’ such as making CPMs
mandatory in clinical guidelines or local policies may in-
crease their uptake. Lack of time is such an important
issue in primary care as demonstrated in both our find-
ings and those of others [12–15, 17] that both dedicated
Table 3 Best practices for CPM development and implementation
in primary care
CPM factors
• The CPM should have a relative advantage to current ways of working.
This could be achieved in the following ways:
○ Focusing on areas where there is a perceived lack of clinical
knowledge or risk of medical litigation
○ Linking outputs to clinical actions
○ Provide ways to enhance, not impede, communication with
patients and colleagues
○ Provide the ability to monitor symptom severity
• CPMs should be as simple and easy to use as possible. This could be
achieved by using only routinely measured risk factors and markers to
calculate the score, then auto populating the result within existing
clinical information systems.
Clinician factors
• Clinicians must be made aware of new CPMs, and if existing ones are
updated
• Information or training on how to use the CPM should be provided
(consistent with providing personalised care), which should also
highlight the advantages of its use.
Contextual factors
• The CPM should be compatible with the pervading culture of the
organisation in which it is being implemented.
• CPM use should be recommended in clinical guidelines or local
policies.
• Dedicated time and resources should be provided to use CPMs.
• Education and training in the use of CPMs should be available.
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resources should be provided to use them, and they
should be as easy and quick to use as possible (as de-
scribed above).
The influence of some factors found in our study is
less clear and warrants further investigation in future
research. Using patient-reported measures in CPMs
may reduce acceptance by clinicians, but conversely may
help facilitate communication with patients. Mandating
CPMs may increase their use, but may adversely affect the
clinician’s sense of professionalism. Clinician seniority and
organisational attitude toward CPMs may also be import-
ant. In particular, there was a suggestion that a clinician
who perceives themselves as more experienced in a clin-
ical area may rely less on a CPM than a less experienced
clinician. These hypotheses could be tested in future
studies of family physicians from other contexts and using
different study designs. For example, an interesting avenue
for further research may involve the ethnographic obser-
vation of how CPMs are used (or not used) in practice,
and how they impact on patient care, rather than relying
on self-reports of physicians.
Conclusions
We investigated the reasons for use and non-use of
CPMs by UK family physicians through a survey and
focus groups. Our findings suggest important factors re-
late to features of the CPM itself, the clinician, and the
context in which it is used. Based on this, we suggest
best practices for the development and implementation
of CPMs, summarised as follows.
The CPM should offer a relative advantage to current
ways of working, and be easy and quick to use, and well
integrated in the clinical workflow. Clinicians should be
trained in the use of CPMs, and their use should be pro-
moted. CPMs should be recommended in guidelines and
policy, and be integrated in the clinical culture.
Our study also found that CPMs were used by partici-
pants in ways that had previously not been reported,
such as communication with other doctors, medico-legal
purposes, and legitimisation of difficult discussions with
patients. It also identified new CPM characteristics that
influence their use, such as the use of patient-reported
data and actionability of results. We considered our find-
ings within the framework of Diffusion of Innovations
theory for health service organisations, which provided
further insights and a structure with which to translate
our results and those from other relevant studies into
practical recommendations for future CPM development
and implementation in primary care.
Appendix
Final survey questions
As a practising family physician or trainee in the North
West you are invited to take part in a short survey
regarding what you think about clinical risk scores such
as QRISK, CHA2DS2-VASc, PHQ-9, Epworth Sleepiness
Scale, or the Wells’ Score. The results from this survey
will be used to make better risk scores. We use risk
scores every day to help us manage patients, so under-
taking this survey will help improve care for patients
and make your life easier too.
1. Do you think family physicians make enough use of
risk scores?
a. Should be used less
b. About right
c. Should be used more
2. What are the main advantages of using risk scores
(rank all answers that apply)
a. Scores QOF points
b. Guides appropriate treatment
c. Motivates patient to make lifestyle changes
d. Justifies treatment decisions made
e. Incorporates large body of evidence
f. Promotes equity of treatment
g. Other (specify):_____________________________
3. Which of the following barriers prevent you from
using risk scores more (rank all answers that apply)
a. Do not have time to use during a consultation
b. Do not add to my clinical judgement
c. Not relevant for use in all patients
d. Not integrated with electronic patient records
e. Lack of link to clinical actions
f. Encourage over-treatment
g. Encourage under-treatment
h. Do not include all risk factors
i. Undermine my professionalism
j. Do not know which risk score to use
k. Other (specify):_____________________________
4. Which of the following benefits (would) encourage
you to make more use of risk scores (rank all
answers that apply)
a. Well incentivised
b. Quick to use
c. Easy to use
d. Add value to clinical judgement
e. Integration with electronic patient records
f. Strong link to clinical action
g. Ensure good treatment decisions
h. Motivate patient to make lifestyle changes
i. Provides justification for clinical decisions
j. Transparency of the methods behind the risk
score
k. Other (specify): _______________________
5. Would further training in understanding and
communicating the results of risk scores
be helpful?
a. Yes, and I would definitely attend such training
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b. Yes, but I would be unlikely to find time to attend
c. No
6. Do you believe that a family physician could
out-perform a risk score in predicting future
outcomes for an individual patient?
a. Yes, almost always
b. Yes fairly regularly
c. No
7. Are there any other comments you wish to make
about the use of risk scores? Please do so below…
8. Are you (tick all that apply):
a. Family physician trainee
b. Salaried family physician
c. Locum family physician
d. Family physician Partner
9. Years since qualified from medical school (specify)
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